SONOMA PHARMACEUTICALS INC's ticker is SNOA and the CUSIP is 83558L105. A total of 2 filers reported holding SONOMA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $0 | – | 600 | 0.0% | 0.00% | – |
Q4 2018 | $0 | -100.0% | 600 | -7.3% | 0.00% | – |
Q3 2018 | $1,000 | 0.0% | 647 | +19.8% | 0.00% | – |
Q2 2018 | $1,000 | -50.0% | 540 | 0.0% | 0.00% | – |
Q1 2018 | $2,000 | -33.3% | 540 | 0.0% | 0.00% | – |
Q4 2017 | $3,000 | -40.0% | 540 | -44.9% | 0.00% | – |
Q3 2017 | $5,000 | -28.6% | 980 | 0.0% | 0.00% | – |
Q2 2017 | $7,000 | -30.0% | 980 | -26.9% | 0.00% | – |
Q1 2017 | $10,000 | +100.0% | 1,340 | +36.7% | 0.00% | – |
Q4 2016 | $5,000 | – | 980 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BARD ASSOCIATES INC | 614,495 | $4,405,000 | 0.41% |
JW Asset Management, LLC | 100,951 | $724,000 | 0.15% |
Hartford Financial Management Inc. | 900 | $6,000 | 0.00% |
Virtu KCG Holdings LLC | 13,161 | $94,000 | 0.00% |
Acrospire Investment Management LLC | 223 | $2,000 | 0.00% |
RAYMOND JAMES & ASSOCIATES | 11,242 | $81,000 | 0.00% |
UBS Group AG | 1,094 | $8,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 1,340 | $10,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 1,014 | $7,000 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 15,019 | $107,000 | 0.00% |